Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard Bupivacaine

Objective. *e purpose of this study is to determine whether (1) liposomal bupivacaine is chondrotoxic; (2) the chondrotoxicity of liposomal bupivacaine differs from standard bupivacaine; and (3) chondrotoxic effects are time dependent. Materials and Methods. We obtained 72 10 mm articular cartilag...

Full description

Bibliographic Details
Main Authors: Travis Farmer, S. Craig Morris, Robert Quigley, Nirav H. Amin, Montri D. Wongworawat, Hasan M. Syed
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Advances in Pharmacological and Pharmaceutical Sciences
Online Access:https://www.hindawi.com/journals/aps/2020/5794187/
id doaj-45395c1687594e98a6fde6b0e8e36e2f
record_format Article
spelling doaj-45395c1687594e98a6fde6b0e8e36e2f2020-11-25T03:15:07ZengHindawi LimitedAdvances in Pharmacological and Pharmaceutical Sciences2633-46902020-01-01202010.1155/2020/5794187Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard BupivacaineTravis Farmer0S. Craig Morris1https://orcid.org/0000-0003-1034-6219Robert Quigley2Nirav H. Amin3Montri D. Wongworawat4Hasan M. Syed5Department of Orthopaedic Surgery, Loma Linda University, 11406 Loma Linda Drive, Suite 218, Loma Linda, CA 92354, USADepartment of Orthopaedic Surgery, Loma Linda University, 11406 Loma Linda Drive, Suite 218, Loma Linda, CA 92354, USADepartment of Pediatric Orthopaedic Surgery, Children’s Hospital at Erlanger, 910 Blackford Street, Chattanooga, TN 37403, USADepartment of Orthopaedic Surgery, VA Loma Linda Healthcare System, 11201 Benton Street, Loma Linda, CA 92357, USADepartment of Orthopaedic Surgery, Loma Linda University, 11406 Loma Linda Drive, Suite 218, Loma Linda, CA 92354, USADepartment of Orthopaedic Surgery, Loma Linda University, 11406 Loma Linda Drive, Suite 218, Loma Linda, CA 92354, USAObjective. *e purpose of this study is to determine whether (1) liposomal bupivacaine is chondrotoxic; (2) the chondrotoxicity of liposomal bupivacaine differs from standard bupivacaine; and (3) chondrotoxic effects are time dependent. Materials and Methods. We obtained 72 10 mm articular cartilage plugs from 12 fresh bovine distal femoral knee joints and exposed them to either saline, 0.5% bupivacaine, or liposomal bupivacaine for either 30 or 90 minutes. Twenty-four hours after treatment, chondrocyte viability was measured with the use of a fluorescent live/dead assay. An ANOVA test of variance was performed followed by a Holm–Sidak test to make pairwise comparisons across conditions. Student’s t-test was used to compare means. Results. Percent viability of cells exposed to liposomal bupivacaine for 30 minutes was less versus saline control (53.9% ± 21.5% vs. 73.7 ± 18.4%, p = 0.035), and this remained significant at 90 minutes (49.1% ± 20.3% vs. 67.2% ± 25.6%, p < 0.001). Liposomal bupivacaine had less chondrotoxic effects when compared with bupivacaine after 90 minutes, with greater viability (49.1% ± 20.3% vs. 21.4% ± 14.0%, p = 0.003). Chondrotoxicity was found to be time dependent within the bupivacaine group (percent viability at 30 min: 45.5 ± 18.2%, 90 min: 21.4 ± 14.0%, p = 0.001); however, liposomal bupivacaine did not demonstrate a significant timedependent chondrotoxic relationship (p = 0.583). Conclusions. Bupivacaine and liposomal bupivacaine are both toxic to chondrocytes. Liposomal bupivacaine is less chondrotoxic than standard bupivacaine and does not demonstrate a timedependent toxicity.https://www.hindawi.com/journals/aps/2020/5794187/
collection DOAJ
language English
format Article
sources DOAJ
author Travis Farmer
S. Craig Morris
Robert Quigley
Nirav H. Amin
Montri D. Wongworawat
Hasan M. Syed
spellingShingle Travis Farmer
S. Craig Morris
Robert Quigley
Nirav H. Amin
Montri D. Wongworawat
Hasan M. Syed
Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard Bupivacaine
Advances in Pharmacological and Pharmaceutical Sciences
author_facet Travis Farmer
S. Craig Morris
Robert Quigley
Nirav H. Amin
Montri D. Wongworawat
Hasan M. Syed
author_sort Travis Farmer
title Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard Bupivacaine
title_short Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard Bupivacaine
title_full Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard Bupivacaine
title_fullStr Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard Bupivacaine
title_full_unstemmed Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard Bupivacaine
title_sort chondrotoxicity of local anesthetics: liposomal bupivacaine is less chondrotoxic than standard bupivacaine
publisher Hindawi Limited
series Advances in Pharmacological and Pharmaceutical Sciences
issn 2633-4690
publishDate 2020-01-01
description Objective. *e purpose of this study is to determine whether (1) liposomal bupivacaine is chondrotoxic; (2) the chondrotoxicity of liposomal bupivacaine differs from standard bupivacaine; and (3) chondrotoxic effects are time dependent. Materials and Methods. We obtained 72 10 mm articular cartilage plugs from 12 fresh bovine distal femoral knee joints and exposed them to either saline, 0.5% bupivacaine, or liposomal bupivacaine for either 30 or 90 minutes. Twenty-four hours after treatment, chondrocyte viability was measured with the use of a fluorescent live/dead assay. An ANOVA test of variance was performed followed by a Holm–Sidak test to make pairwise comparisons across conditions. Student’s t-test was used to compare means. Results. Percent viability of cells exposed to liposomal bupivacaine for 30 minutes was less versus saline control (53.9% ± 21.5% vs. 73.7 ± 18.4%, p = 0.035), and this remained significant at 90 minutes (49.1% ± 20.3% vs. 67.2% ± 25.6%, p < 0.001). Liposomal bupivacaine had less chondrotoxic effects when compared with bupivacaine after 90 minutes, with greater viability (49.1% ± 20.3% vs. 21.4% ± 14.0%, p = 0.003). Chondrotoxicity was found to be time dependent within the bupivacaine group (percent viability at 30 min: 45.5 ± 18.2%, 90 min: 21.4 ± 14.0%, p = 0.001); however, liposomal bupivacaine did not demonstrate a significant timedependent chondrotoxic relationship (p = 0.583). Conclusions. Bupivacaine and liposomal bupivacaine are both toxic to chondrocytes. Liposomal bupivacaine is less chondrotoxic than standard bupivacaine and does not demonstrate a timedependent toxicity.
url https://www.hindawi.com/journals/aps/2020/5794187/
work_keys_str_mv AT travisfarmer chondrotoxicityoflocalanestheticsliposomalbupivacaineislesschondrotoxicthanstandardbupivacaine
AT scraigmorris chondrotoxicityoflocalanestheticsliposomalbupivacaineislesschondrotoxicthanstandardbupivacaine
AT robertquigley chondrotoxicityoflocalanestheticsliposomalbupivacaineislesschondrotoxicthanstandardbupivacaine
AT niravhamin chondrotoxicityoflocalanestheticsliposomalbupivacaineislesschondrotoxicthanstandardbupivacaine
AT montridwongworawat chondrotoxicityoflocalanestheticsliposomalbupivacaineislesschondrotoxicthanstandardbupivacaine
AT hasanmsyed chondrotoxicityoflocalanestheticsliposomalbupivacaineislesschondrotoxicthanstandardbupivacaine
_version_ 1715267344007168000